Main surgery procedures and mechanisms for treating type 2 diabetes

doi:10.3969/j.issn.1006-7795.2015.02.029

Abstract

Abstract:

Bariatric surgery leads to glycemia normalization in most type 2 diabetes patients. There are a variety of surgery procedures and mechanisms for treating type 2 diabetes. Moreover, the effectiveness is different. These make it difficult for clinician to choose the appropriate surgery procedure. The objective of this study is to review the main surgery procedures and mechanisms for treating type 2 diabetes, contributing to making appropriate choice for clinician.

Key words: diabetes, surgery procedures, mechanisms

CLC Number:

R656

Zhang Zhen, Kong Ke. Main surgery procedures and mechanisms for treating type 2 diabetes[J]. Journal of Capital Medical University, 2015, 36(2): 318-323.

References

[1] Mokdad A H, Ford E S, Bowman B A, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001[J]. JAMA, 2003,289(1):76-79.
[2] Pories W J, Swanson M S, MacDonald K G, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus[J]. Ann Surg, 1995,222(3):339-350.
[3] Schauer P R, Bhatt D L, Kirwan J P, et al. Bariatric surgery versus intensive medical therapy for diabetes-3-year outcomes[J]. N Engl J Med, 2014,370(21):2002-2013.
[4] Franco J V, Ruiz P A, Palermo M, et al. A review of studies comparing three laparoscopic procedures in bariatric surgery:sleeve gastrectomy, Roux-en-Y gastric bypass and adjustable gastric banding[J]. Obes Surg, 2011,21(9):1458-1468.
[5] Wang Y, Liu J. Plasma ghrelin modulation in gastric band operation and sleeve gastrectomy[J]. Obes Surg, 2009,19(3):357-362.
[6] Vetter M L, Ritter S, Wadden T A, et al. Comparison of bariatric surgical procedures for diabetes remission:efficacy and mechanisms[J]. Diabetes Spectr, 2012,25(4):200-210.
[7] 仲明惟,刘少壮,张光永,等.袖状胃切除术后减重及2型糖尿病缓解的机制[J].腹腔镜外科杂志,2014,19(1):54-56.
[8] Schauer P R, Kashyap S R, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes[J]. N Engl J Med, 2012,366(17):1567-1576.
[9] Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes[J]. N Engl J Med, 2012,366(17):1577-1585.
[10] Ribaric G, Buchwald J N, McGlennon T W. Diabetes and weight in comparative studies of bariatric surgery vs conventional medical therapy:a systematic review and meta-analysis[J]. Obes Surg, 2014,24(3):437-455.
[11] 张晓娟,杜涓,杜潇,等.腹腔镜下胃转流术治疗肥胖型2型糖尿病的疗效分析[J].中国普外基础与临床杂志,2012,19(12):1272-1277.
[12] 廉东波,朱斌,宫轲,等.腹腔镜胃肠旁路手术治疗肥胖型和非肥胖型2型糖尿病疗效分析[J].中国实用外科杂志,2013,33(3):214-216.
[13] Geloneze B, Geloneze S R, Fiori C, et al. Surgery for nonobese type 2 diabetic patients:an interventional study with duodenal-jejunal exclusion[J]. Obes Surg, 2009,19(8):1077-1083.
[14] Malapan K, Goel R, Tai C M, et al. Laparoscopic Roux-en-Y gastric bypass for nonobese type Ⅱ diabetes mellitus in Asian patients[J]. Surg Obes Relat Dis, 2014,10(5):834-840.
[15] Rubino F, Marescaux J. Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes:a new perspective for an old disease[J]. Ann Surg, 2004,239(1):1-11.
[16] Lemanowicz A, Serafin Z. Imaging of patients treated with bariatric surgery[J]. Pol J Radiol, 2014,79(1):12-19.
[17] Guo X, Yin K, Chen B L, et al. Impacts of laparoscopic bariatric surgery on GLP-1 and Ghrelin level in patients with type 2 diabetes mellitus[J]. Zhonghua Wai Ke Za Zhi, 2013,51(4):323-327.
[18] Laferrere B, Teixeira J, McGinty J, et al. Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes[J]. J Clin Endocrinol Metab, 2008,93(7):2479-2485.
[19] Whitson B A, Leslie D B, Kellogg T A, et al. Entero-endocrine changes after gastric bypass in diabetic and nondiabetic patients:a preliminary study[J]. J Surg Res, 2007,141(1):31-39.
[20] Jacobsen S H, Olesen S C, Dirksen C, et al. Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in nondiabetic subjects[J]. Obes Surg, 2012,22(7):1084-1096.
[21] Bose M, Teixeira J, Olivan B, et al. Weight loss and incretin responsiveness improve glucose control independently after gastric bypass surgery[J]. J Diabetes, 2010,2(1):47-55.
[22] Allen R E, Hughes T D, Ng J L, et al. Mechanisms behind the immediate effects of Roux-en-Y gastric bypass surgery on type2 diabetes[J]. Theor Biol Med Model, 2013,10:45.
[23] Ionut V, Bergman R N. Mechanisms responsible for excess weight loss after bariatric surgery[J]. J Diabetes Sci Technol, 2011,5(5):1263-1282.
[24] Mumphrey M B, Patterson L M, Zheng H, et al. Roux-en-Y gastric bypass surgery increases number but not density of CCK-, GLP-1-, 5-HT-, and neurotensin-expressing enteroendocrine cells in rats[J]. Neurogastroenterol Motil, 2013,25(1):e70-e79.
[25] Cummings D E, Weigle D S, Frayo R S, et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery[J]. N Engl J Med, 2002,346(12):1623-1630.
[26] Chronaiou A, Tsoli M, Kehagias I, et al. Lower ghrelin levels and exaggerated postprandial peptide-YY, glucagon-like peptide-1, and insulin responses, after gastric fundus resection, in patients undergoing Roux-en-Y gastric bypass:a randomized clinical trial[J]. Obes Surg, 2012,22(11):1761-1770.
[27] Ybarra J, Bobb ioni-Harsch E, Chassot G, et al. Persistent correlation of ghrelin plasma levels with body mass index both in stable weight conditions and during gastric-bypass-induced weight loss[J]. Obes Surg, 2009,19(3):327-331.
[28] Beckman L M, Beckman T R, Earthman C P. Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass procedure:a review[J]. J Am Diet Assoc, 2010,110(4):571-584.
[29] Sekirov I, Russell S L, Antunes L C, et al. Gut microbiota in health and disease[J]. Physiol Rev, 2010,90(3):859-904.
[30] Kinross J M, Darzi A W, Nicholson J K. Gut microbiome-host interactions in health and disease[J]. Genome Med, 2011,3(3):14.
[31] Furet J P, Kong L C, Tap J, et al. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss:links with metabolic and low-grade inflammation markers[J]. Diabetes, 2010,59(12):3049-3057.
[32] Li J V, Ashrafian H, Bueter M, et al. Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk[J]. Gut, 2011,60(9):1214-1223.
[33] Stachowicz N, Kiersztan A. The role of gut microbiota in the pathogenesis of obesity and diabetes[J]. Postepy Hig Med Dosw(online), 2013,67:288-303.
[34] Liou A P, Paziuk M, Luevano J M Jr, et al. Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity[J]. Sci Transl Med, 2013,5(178):178ra41.
[35] Felig P, Marliss E, Cahill G F Jr. Plasma amino acid levels and insulin secretion in obesity[J]. N Engl J Med, 1969,281(15):811-816.
[36] Wang T J, Larson M G, Vasan R S, et al. Metabolite profiles and the risk of developing diabetes[J]. Nat Med, 2011,17(4):448-453.
[37] Laferrère B, Reilly D, Arias S, et al. Differential metabolic impact of gastric bypass surgery versus dietary intervention in obese diabetic subjects despite identical weight loss[J]. Sci Transl Med, 2011,3(80):80re2.
[38] Lindqvist A, Spegel P, Ekelund M, et al. Effects of ingestion routes on hormonal and metabolic profiles in gastric-bypassed humans[J]. J Clin Endocrinol Metabol, 2013,98(5):E856-E861.
[39] Karra E, Yousseif A, Batterham R L. Mechanisms facilitating weight loss and resolution of type 2 diabetes following bariatric surgery[J]. Trends Endocrinol Metabolism, 2010,21(6):337-344.
[40] Odstrcil E A, Martinez J G, Santa Ana C A, et al. The contribution of malabsorption to the reduction in net energy absorption after long-limb Roux-en-Y gastric bypass[J]. Am J Clin Nutr, 2010,92(4):704-713.
[41] 孙秉赋,张博,栾明翰.手术治疗糖尿病的临床及相关研究进展[J].中国煤炭工业医学杂志,2013,16(12):2085-2088.
[42] Browning K N, Hajnal A. The effects of bariatric surgery-will understanding its mechanism render the knife unnecessary?[J]. Expert Rev Gastroenterol Hepatol, 2014,8(1):1-4.